https://www.selleckchem.com/products/2-d08.html
1%, disease-free survival 70.2%, distant metastasis-free survival 75.2%, and LC 86.7%. #link# Following NA-CRT, a median reduction of 54.7% was observed in tumor PET avidity; once resected, median tumor necrosis of 60.0% with no viable tumor cells was detected in 13.8% of the cases. Posttreatment resection margins were negative in all patients, with 27.6% having a margin of ≤1 mm. Delays of over 6 weeks following the end of radiation treatment to surgical resection occurred in 20.7% cases and was suggestive of inferior LC (92.8% vs. 68.6%
Like
Comment
Share